Aggregated China Media News & Blogs



HIV Antiviral Compound Licensed To Guangdong Lantai Viewland Pharmaceutical

Aggregated Source: ChinaCSR.com
March 8, 2007|

Sweden's Medivir AB and Guangdong Lantai Viewland Pharmaceutical have signed a licensing agreement for MIV-160 (MV026048), a non-nucleoside HIV reverse transcriptase inhibitor in late pre-clinical development.

Original URL: Click here to visit original article
Copyright ChinaCSR.com
Print This Post Print This Post | Email To Friend

1 Stars2 Stars3 Stars4 Stars5 Stars6 Stars7 Stars8 Stars9 Stars10 Stars

21 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 1021 Votes | Average: 5.62 out of 10 (21 votes, average: 5.62 out of 10)


Related Info:
  • Food And Pharmaceutical Industries Plan Social Responsibility Standards In Guangdong
  • Guangdong 3G Industry Alliance Licensed
  • Guangdong Releases Weather Emergency Measures
  • SFDA Wants Better Pharmaceutical Advertising
  • Chinese Medicine Manufacturers Punished For Disobeying GMP

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |